HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,090,957 | -61.8% | 9,430 | -66.0% | 0.00% | -50.0% |
| Q2 2023 | $2,854,910 | +44.3% | 27,758 | +53.1% | 0.00% | 0.0% |
| Q1 2023 | $1,979,017 | -15.9% | 18,133 | -12.4% | 0.00% | 0.0% |
| Q4 2022 | $2,354,275 | +4.2% | 20,688 | -43.4% | 0.00% | 0.0% |
| Q3 2022 | $2,260,000 | -1.7% | 36,521 | +26.8% | 0.00% | 0.0% |
| Q2 2022 | $2,298,000 | +27.5% | 28,809 | +68.1% | 0.00% | 0.0% |
| Q1 2022 | $1,803,000 | -42.8% | 17,133 | -41.4% | 0.00% | -33.3% |
| Q4 2021 | $3,151,000 | +4.6% | 29,239 | +6.3% | 0.00% | 0.0% |
| Q3 2021 | $3,012,000 | +14.5% | 27,501 | -2.1% | 0.00% | 0.0% |
| Q2 2021 | $2,630,000 | +19.7% | 28,085 | +17.7% | 0.00% | 0.0% |
| Q1 2021 | $2,197,000 | +46.7% | 23,865 | +16.6% | 0.00% | +50.0% |
| Q4 2020 | $1,498,000 | +39.9% | 20,473 | +48.5% | 0.00% | 0.0% |
| Q3 2020 | $1,071,000 | +85.3% | 13,782 | +32.5% | 0.00% | +100.0% |
| Q2 2020 | $578,000 | – | 10,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |